SCHEMBL7415735

SCHEMBL7415735

N=C(N)NOCCCOc1ccc(C[C@H](NS(=O)(=O)c2ccc(Br)c(Br)c2)C(=O)OC(=O)C(F)(F)F)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 4/20 0.38
TMPRSS6 Q8IU80 4/20 0.38
ITGB3 P05106 9/20 0.37
ITGA2B P08514 9/20 0.37
CA12 O43570 3/20 0.36
CA1 P00915 3/20 0.36
CA2 P00918 3/20 0.36
CA9 Q16790 3/20 0.36
ADAM10 O14672 2/20 0.35
MMP2 P08253 2/20 0.35
MMP9 P14780 2/20 0.35
ADAM8 P78325 2/20 0.35
ADAM17 P78536 2/20 0.35
MMP12 P39900 1/20 0.35
MMP14 P50281 1/20 0.35
ITGAV P06756 3/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
BACE1 P56817 1/20 0.35
CA4 P22748 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7412629 0.91 CTSL (0.43) F2TMPRSS6ITGB3ITGA2BADAM10
SCHEMBL7419584 0.90 F2 (0.42) F2TMPRSS6ITGB3ITGA2BITGAV
SCHEMBL7412728 0.89 F2 (0.39) F2TMPRSS6ITGB3ITGA2BCA12
Trifluoroacetic Acid SCHEMBL7415728 0.89 ITGB3 (0.46) F2TMPRSS6ITGB3ITGA2BCA12
SCHEMBL7417130 0.89 F2 (0.45) F2TMPRSS6ITGB3ITGA2B
SCHEMBL7415413 0.89 TMPRSS6 (0.38) F2TMPRSS6ITGB3ITGA2BITGAV
SCHEMBL7415235 0.88 KCNA5 (0.44) F2TMPRSS6ITGB3ITGA2BMMP2
SCHEMBL7699209 0.88 F2 (0.42) F2TMPRSS6ITGB3ITGA2BMMP2
SCHEMBL7416867 0.88 NPSR1 (0.40) F2TMPRSS6ITGB3ITGA2BMMP2
SCHEMBL7694791 0.88 MMP2 (0.45) F2TMPRSS6ITGB3ITGA2BCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6344484-B1 TREATMENT OF TUMOR GROWTH, METASTASIS, OSTEOPOROSIS, RESTENOSIS, INFLAMMATION, MACULAR DEGENERATION, DIABETIC RETINOPATHY, AND RHEUMATOID ARTHRITIS 3-DIMENSIONAL PHARMACEUTICALS, INC. 2002-02-05 US disclosed
EP-1159262-A1 TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2001-12-05 EP disclosed
WO-2000047552-A1 TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2000-08-17 WO disclosed